Jss medical research montreal

Additional regional offices are located in Ahmedabad, Bangalore, Chennai and Mumbai. For our biotech clients the expansion will provide them with access to patients and high quality research sites that will facilitate the completion of their clinical development jss medical research montreal. This is an important step for JSS Medical Research in its evolution as a niche global CRO and a major achievement for the Canadian and Quebec Health Care Research Industry because it is testimony to the fact that the quality and value of the scientific work done here transcends geographic borders and limits. John S.

Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access. Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry. Policy Get Involved. Join BIOAction. View Advocacy Toolkit. Patient Advocacy.

Jss medical research montreal

Recognized as a leading clinical epidemiologist and one of the top trauma researchers in Canada, he possesses extensive expertise in health services research, clinical trials, and offers services as a Research and Epidemiological Consultant for numerous pharmaceutical companies, hospitals and government organizations and agencies. Watson holds a M. Her experience extends to all facets of the CRO business, and multiple therapeutic areas. Watson currently holds the position of Chief Business Officer, and is head of the business development team. She holds a B. She has over 25 years' of experience in medical research management. Currently Chief Operations Officer, Mrs. Boukas has been essential in structuring and implementing programs at JSS Medical Research Inc to facilitate project management, site recruitment, data capture and study tracking. Boukas holds a B. She has over twenty-five years' experience in research. Harvey holds a B. With 20 years' experience in the pharmaceutical industry, she has held positions in both Commercial and Medical departments. Harvey currently holds the position of Director, Clinical Operations at JSS Medical Research Inc, functionally and operationally overseeing a team of project and data managers in the development and implementation of clinical studies.

Cost and Value of Biopharmaceuticals. BIO Leadership.

Theralase anticipates executing further agreements in the Quebec biotech sector worth several million dollars over the next 12 to 18 months. Internationally, there are , new cases a year. Risk factors for bladder cancer increasingly are being linked to smoking, as countries with a higher prevalence of smoking have demonstrated higher rates of bladder cancer. Theralase has discovered a treatment that destroys cancer cells and prevents their reoccurrence during preclinical testing and is quickly advancing to human clinical trials. The Globe and Mail reported on September 8, that Canada is experiencing a serious shortage of an essential drug for the treatment of bladder cancer. The shortfall, which is due to manufacturing problems at plants operated by two different pharmaceutical companies, could have major consequences for patients.

For Businesses. Find the best places and services. See more. Magazine , Newspaper , Bookmaker's offices , Passenger automobile and electric transport enterprises , Publishing house , Cloth wholesaler , IT Consulting. Country club. Online pharmacy , Drug stores , Home medical equipment , Homeopathic remedies , Medical equipment store , Medication manufacturing , Blood pressure monitors. Day care , Children's camps , Kids' library , Nursery , Private kindergarten , Preparing for school , Children's art center.

Jss medical research montreal

Skip to main content. Published: May 10, This clinical service portfolio addition will enable the GD 3 member companies to expand their full-service drug research and discovery services. JSS Medical Research's skilled team of world-class scientists will work synergistically and augment GD 3 's existing platform of services in clinical trial support, including clinical trial management, protocol development, biostatistics, clinical data management, clinical study monitoring, biostatistics and medical writing, medical monitoring, safety reporting, and project management for the development and approval of pharmaceutical, nutraceutical and medical device products. The merger of the two companies creates an organization that will deliver state-of-the-art scientific support and services to our combined and growing list of pharmaceutical, biotechnology and medical device clients.

Common multiples of 8 and 10

Investors and Media Overview. Benefits By Sector. John S. Trial Design. John S. Good Day BIO. The Globe and Mail reported on September 8, that Canada is experiencing a serious shortage of an essential drug for the treatment of bladder cancer. This clinical service portfolio addition will enable the GD 3 member companies to expand their full-service drug research and discovery services. We'll assume you're ok with this, but you can opt-out if you wish. Choose Specialty Analytics. Privacy Policy. Dr Machado obtained his medical degree from the University of Pune, India. Professional Development.

Objective: Although persons with lower socioeconomic status SES generally have poorer health status for many medical conditions, the association of SES with symptom severity in fibromyalgia FM is unknown. The subjective symptoms of FM may be influenced by personal perceptions, and environmental and psychosocial factors. Therefore SES may influence symptom expression and severity.

Contact Info. Members Only. Additional information is available at www. BIO Policy Committees. Event Portfolio. First and foremost, JSS has built its reputation on the successful design, execution, analysis and publication of FDA and Health Canada-approved human clinical trials. Non-necessary Non-necessary. It provides full range of services including project management, data management, clinical trial supplies management, regulatory services and medical writing. Become a BIO Member. Theralase has discovered a treatment that destroys cancer cells and prevents their reoccurrence during preclinical testing and is quickly advancing to human clinical trials.